SCHEMBL2222920

SCHEMBL2222920

CC(C)OC(=O)c1cccnc1N1CCN(Cc2ccc(OCc3c(F)cccc3Cl)cc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
NPSR1 Q6W5P4 2/20 0.54
POLB P06746 2/20 0.54
KDM4E B2RXH2 1/20 0.54
LMNA P02545 1/20 0.53
TDP1 Q9NUW8 3/20 0.45
ALDH1A1 P00352 2/20 0.44
KMT2A Q03164 1/20 0.44
ATM Q13315 1/20 0.44
GPR6 P46095 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CACNA1G O43497 4/20 0.41
KCNH2 Q12809 2/20 0.41
ALOX15 P16050 1/20 0.40
HPGD P15428 1/20 0.40
SGMS2 Q8NHU3 1/20 0.39
NPC1 O15118 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2225233 0.95 MAPT (0.56) MAPTL3MBTL1NPSR1POLBKDM4E
SCHEMBL2225657 0.94 MAPT (0.58) MAPTL3MBTL1NPSR1POLBKDM4E
SCHEMBL2221614 0.93 KDM4E (0.54) MAPTL3MBTL1NPSR1POLBKDM4E
SCHEMBL2223056 0.92 L3MBTL1 (0.58) MAPTL3MBTL1NPSR1POLBKDM4E
SCHEMBL12517082 0.92 MAPT (0.53) MAPTL3MBTL1NPSR1POLBKDM4E
SCHEMBL2221569 0.92 MAPT (0.54) MAPTL3MBTL1NPSR1POLBKDM4E
SCHEMBL2224521 0.90 MAPT (0.54) MAPTL3MBTL1NPSR1POLBKDM4E
SCHEMBL2221092 0.89 KDM4E (0.51) MAPTL3MBTL1NPSR1POLBKDM4E
SCHEMBL2221823 0.88 MAPT (0.53) MAPTL3MBTL1NPSR1POLBKDM4E
Hydrochloric Acid SCHEMBL2223177 0.87 MAPT (0.52) MAPTL3MBTL1NPSR1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2729149-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS Glaxo Group Limited (GB) 2014-05-14 EP claimed
US-20140121213-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS GLAXO GROUP LIMITED (GB) 2014-05-01 US claimed
US-20130023541-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS GLAXO GROUP LIMITED 2013-01-24 US claimed
WO-2013006596-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS GLAXO GROUP LIMITED (GB) 2013-01-10 WO claimed
EP-2523665-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS Glaxo Group Limited (GB) 2012-11-21 EP claimed
WO-2011088201-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS GLAXO GROUP LIMITED (GB) 2011-07-21 WO claimed
EP-2729149-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS Glaxo Group Limited (GB) 2014-05-14 EP disclosed
US-20140121213-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS GLAXO GROUP LIMITED (GB) 2014-05-01 US disclosed
US-20140121213-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS GLAXO GROUP LIMITED (GB) 2014-05-01 US disclosed
US-20140121213-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS GLAXO GROUP LIMITED (GB) 2014-05-01 US disclosed
US-20130023541-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS GLAXO GROUP LIMITED 2013-01-24 US disclosed
US-20130023541-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS GLAXO GROUP LIMITED 2013-01-24 US disclosed
US-20130023541-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS GLAXO GROUP LIMITED 2013-01-24 US disclosed
WO-2013006596-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS GLAXO GROUP LIMITED (GB) 2013-01-10 WO disclosed
EP-2523665-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS Glaxo Group Limited (GB) 2012-11-21 EP disclosed
WO-2011088201-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS GLAXO GROUP LIMITED (GB) 2011-07-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130023541-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS KCNB1, KCNB2, SCNN1B MAPT 1880/4885L3MBTL1 3824/4885NPSR1 1187/4885
US-20140121213-A1 VOLTAGE-GATED SODIUM CHANNEL BLOCKERS KCNB1, SCNN1B, TRPV1 MAPT 2771/4885L3MBTL1 4180/4885NPSR1 1113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.